<code id='750418F43D'></code><style id='750418F43D'></style>
    • <acronym id='750418F43D'></acronym>
      <center id='750418F43D'><center id='750418F43D'><tfoot id='750418F43D'></tfoot></center><abbr id='750418F43D'><dir id='750418F43D'><tfoot id='750418F43D'></tfoot><noframes id='750418F43D'>

    • <optgroup id='750418F43D'><strike id='750418F43D'><sup id='750418F43D'></sup></strike><code id='750418F43D'></code></optgroup>
        1. <b id='750418F43D'><label id='750418F43D'><select id='750418F43D'><dt id='750418F43D'><span id='750418F43D'></span></dt></select></label></b><u id='750418F43D'></u>
          <i id='750418F43D'><strike id='750418F43D'><tt id='750418F43D'><pre id='750418F43D'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:24314
          Daphne Koller -- biotech coverage from STAT
          Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

          New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

          Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

          advertisement

          But what exactly is Koller building?

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more
          Vertex cell therapy lets patients with type 1 diabetes stop insulin
          Vertex cell therapy lets patients with type 1 diabetes stop insulin

          CraigF.Walker/TheBostonGlobeVertexPharmaceuticalssaidFridaythat,overayearafterreceivingthecompany’ss

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Penis shrinkage, a side effect of prostate cancer surgery, is temporary

          AdoctorperformsaroboticprostatectomyatUniversityofChicagoMedicalCenter.M.SpencerGreen/APIt’sbeencall